APA (7th ed.) Citation

R, N., M, A., PC, P., C, B., F, G., P, C., . . . A, C. (2022). Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease. Reviews in cardiovascular medicine, 23(3), 106. https://doi.org/10.31083/j.rcm2303106

Chicago Style (17th ed.) Citation

R, Nevola, et al. "Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease." Reviews in Cardiovascular Medicine 23, no. 3 (2022): 106. https://doi.org/10.31083/j.rcm2303106.

MLA (9th ed.) Citation

R, Nevola, et al. "Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease." Reviews in Cardiovascular Medicine, vol. 23, no. 3, 2022, p. 106, https://doi.org/10.31083/j.rcm2303106.